semaglutide causes blindness Understanding and Its Impact on Vision Comparative ocular outcomes of tirzepatide

MHRA-authorised options include semaglutide (Wegovy) under NICE TA875 and tirzepatide (Mounjaro) under NICE TA1026, both available through specialist NHS weight management services for eligible patients meeting defined BMI and comorbidity criteria

Elucidating mechanisms of action in relation to cardiorenal protection Questions remain about the mechanism of action of SGLT2 inhibitors and GLP-RAs, particularly in relation to the cardiorenal benefits observed in some diabetes CVOTs [110,111,112] (Additional file 2: Fig

Evening routine design Create a 30-60 minute wind-down routine that signals to the body and brain that sleep is approaching

Upon sacrifice, we assessed retinal disturbances, particularly those in the inner nuclear layer and the inner plexiform layer

Data from the trials administered at weeks four, eight, and twelve of the study were recorded